News Releases

2004 Archive

December 13, 2004 Generic Pharmaceutical Industry Pleased Government Acknowledges Need to Stop Evergreening of Drug Patents
Canada’s generic drug makers today welcomed proposed regulatory changes to limit the practice of “evergreening” of drug patents but cautioned that the amendments could still allow multiple patent strategies to delay access to lower-cost generic medicines. | read more...
December 6, 2004 PATENTLY ABSURD: New Report Shows Canadians Paying More for Prescription Drugs Due to “Evergreening” of Drug Patents
Canadians are paying higher prices for prescription drugs for years longer than they should because of abusive strategies used by brand-name pharmaceutical companies to extend their market monopolies, according to a new study. Patently Absurd: Evergreening of pharmaceutical patent protection under the Patented Medicines (Notice of Compliance) Regulations of Canada’s Patent Act, was released today by commercial litigation lawyer Edward Hore. | read more...
September 17, 2004 Generic Drug Industry Supports First Ministers’ National Pharmaceuticals Strategy
Canada’s generic drug makers today congratulated First Ministers on their National Pharmaceuticals Strategy, particularly the action plan to accelerate access to non-patented drugs. | read more...
September 10, 2004 Generic Drug Makers Table $5-billion in Savings to Help Broker Pharmacare Deal
Generic drug makers today put $5-billion in prescription drug cost savings on the table in an effort to help broker a deal between Canada’s First Ministers on prescription drug coverage for Canadians. | read more...
July 30, 2004 Generic pharmaceutical industry welcomes premiers’ interest in enhanced prescription drug coverage for Canadians Generic drug makers ready with proposals to save billions in Rx drug costs
Canada’s generic drug makers today welcomed reports that Canada’s premiers and territorial leaders will pursue improved prescription drug coverage for Canadians at next month’s meeting with Prime Minister Paul Martin, and offered their assistance to help control rapidly increasing costs. | read more...
May 20, 2004 Generic drug makers table two proposals providing $50-million in annual cost-savings at Quebec Symposium
Canada’s generic pharmaceutical industry today put forward two proposals to save the Quebec government $50-million annually in the cost of its drug benefit program. The proposals were tabled today at the Ministry of Health’s two-day symposium on optimal drug use in Quebec City. | read more...
May 6, 2004 Important notice regarding buying drugs via internet
Some people are choosing to buy their medicines online. The Canadian Generic Pharmaceutical Association urges buyers to be careful that they use reputable suppliers to ensure that they get safe, quality drugs. | read more...
April 20, 2004 Government Amendments to Bill C-9 Fall Short Obstacles overshadow improvements in delivering drugs to developing nations
Government amendments to Bill C-9 tabled today fall short in making the legislation effective in delivering Canadian-made generic pharmaceuticals to developing countries facing health emergencies. | read more...
February 26, 2004 Generic Drug Industry Offers Improvements to Access to Medicines Bill Providing affordable generic medicines to developing countries is important and achievable with changes
Canada’s generic drug makers today proposed several amendments to help ensure Bill C-9 will be effective in delivering Canadian-made generic pharmaceuticals to developing countries facing health emergencies. | read more...
February 12, 2004 Access to Medicines Bill Needs Major Changes to be Effective: Generic Drug Industry Brand-name drug makers hijack Canada’s landmark initiative
Legislation reinstated in the House of Commons today will not deliver Canadian-made generic drugs to people in developing countries who desperately need them, according to Canada’s generic pharmaceutical industry. | read more...
< back to news index		TOP